Roche Bolsters Pipeline with Poseida and Kiniksa Deals
By Lucy Haggerty
Pharma Deals Review: Vol 2022 Issue 8 (Table of Contents)
Published: 8 Aug-2022
DOI: 10.3833/pdr.v2022.i8.2713 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Starting August with a bang, Roche has entered into two deals with Poseida Therapeutics and Kiniksa Pharmaceuticals to bolster its oncology and inflammatory disease pipelines...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS